openPR Logo
Press release

Global Cancer Nanomedicine Market Outlook 2022 Report

05-07-2018 06:35 AM CET | Health & Medicine

Press release from: Kuick Resarch

“Global Cancer Nanomedicine Market Outlook 2022” Report Highlights:

* Overview and Mechanism of Action of Nanomedicine
* Nanomedicine Engineering: Design and Strategy
* Cancer Nanomedicine as Diagnostic and Therapeutics Tool
* Global Cancer Nanomedicine Market Overview and Dynamics
* Global Cancer Nanomedicine Clinical Pipeline by Company, Indication and Phase
* Global Cancer Nanomedicine Clinical Pipeline: 124 Drug
* Marketed Cancer Nanomedicine: 8 Drugs

Download Report Sample Weblink:

https://www.kuickresearch.com/report-global-cancer-nanomedicine-market-outlook-2022.php

For Report Sample Contact: neeraj@kuickresearch.com

Table of Contents

Cancer Nanomedicine: An Optimistic Avenue
1.1 Introduction
1.2 Emergence of Nanomedicines

Prerequisite of Nanomedicines
2.1 Conventional Cancer Treating Approaches
2.2 Nanomedicines: Overcoming the Hurdles

Diversification of Nanomedicines
3.1 Classification on Basis of Constituents
3.1.1 Inorganic Nanoparticles
3.1.2 Organic Nanoparticles
3.2 Classification on Basis of Applicability
3.2.1 Nanomedicine as Diagnostic Agents
3.2.2 Nanomedicine as Therapeutic Agents
3.2.3 Nanomedicine as Drug Delivery Agents
3.3 Classification on Basis of Dimensions

Mechanism of Action of Nanomedicine
4.1 Targeting Tumor Cells
4.1.1 Passive Targeting
4.1.2 Active Targeting
4.2 Nanocarrier - Drug Complex
4.2.1 Liposomes
4.2.2 Dendrimers
4.2.3 Micelles
4.2.4 Inorganic Nanocarriers
4.3 Drug Release Systems

Nanomedicine Engineering: Design and Strategy
5.1 Organic Nanoparticles as Nanomedicines
5.1.1 Polymeric Nanoparticle
5.1.2 Lipid Organic Nanoparticles
5.2 Inorganic Nanoparticles as Nanomedicines
5.2.1 Synthesis of Gold Nanoparticle

Cancer Nanomedicine as Diagnostic Tool
6.1 Detection of Cancer Biomarkers
6.1.1 Detection of Circulating Tumor Cell
6.2 Diagnostic Device and Nanoprobes
6.2.1 Biosensors
6.2.2 Microarrays
6.3 Quantum Dots for Early Cancer Detection
6.3.1 Detection of primary Cancers
6.3.2 Quantum Dots for Tumor Imaging

Cancer Therapeutics with Nanomedicines
7.1 Nanomedicine as Therapeutic Agents
7.1.1 Photodynamic Therapy
7.1.2 Photo Thermal Therapy
7.2 Nanomedicines as Prophylactic and Therapeutic Approach
7.2.1 Cancer Cell Destruction
7.3 Nanomedicine in Breast Cancer
7.4 Nanomedicine in Pancreatic Cancer
7.5 Nanomedicine in Brain Cancer
7.6 Nanomedicine in Lung Cancer

Cancer Imaging with Nanomedicine
8.1 Positron Emission Tomography
8.1.1 Applications in various Cancers
8.2 Single Photon Emitted Tomography
8.2.1 Computed Tomography
8.3 Magnetic Resonance Imaging (MRI)
8.3.1 Optical Imaging

Drug Delivery with Nanomedicines
9.1 Nanocarrier and Chemotherapy
9.1.1 Peptide Nanomedicine- An Example of Nanocarrier Chemotherapy
9.2 Nanomedicine Endocytosis and Intracellular Mechanisms
9.3 Factors Affecting Drug Delivery

Global Cancer Nanomedicine Market Overview
10.1 Current Market Scenario
10.2 Global Cancer Nanomedicine Clinical Pipeline Overview

Global Nanomedicine Market Dynamics
11.1 Encouraging Market Aspects
11.2 Commercialization Challenges

Global Cancer Nanomedicine Future Prospect

Global Cancer Nanomedicine Clinical Pipeline by Company, Indication and Phase
13.1 Research
13.2 Preclinical
13.3 Phase-I
13.4 Phase-I/II
13.5 Phase-II
13.6 Phase-III

Marketed Cancer Nanomedicine Clinical Insight by Company, Indication and Phase
14.1 Caelyx and Doxil
14.2 Albumin-Bound Paclitaxel (Abraxane and Coraxane)
14.3 Nilotinib (Tasigna)
14.4 Paclitaxel Polymeric Micelle Formulation (Cynviloq and Genexol-PM)
14.5 Paclitaxel Liposomal
14.6 Vincristine Liposomal (Marqibo)
14.7 Rexin-G
14.8 Paclitaxel Nanoparticle (Nanoxel)

Competitive Landscape
15.1 Abraxis BioScience
15.2 Access Pharmaceuticals
15.3 Alnylam Pharmaceuticals
15.4 Amgen
15.5 Arrowhead Research
15.6 BIND Therapeutics
15.7 Cadila Healthcare
15.8 Celegen Corporation
15.9 Celsion Corporation
15.10 Genzyme Corporation
15.11 Merck
15.12 NanoCarrier
15.13 Nippon Kayaku
15.14 Nanobiotix
15.15 Novavax
15.16 Pfizer
15.17 Roche
15.18 Samyang
15.19 Sanofi
15.20 Takeda Pharmaceutical

Figure 1-1: Goals of Nanomedicines
Figure 2-1: Advantages of Nanomedicines over Conventional Therapies
Figure 3-1: Various Classes of Nanomedicines
Figure 3-2: Classification of Nanoparticles
Figure 3-3: Classification on Basis of Applicability
Figure 3-4: Dimensional Nanoconstructs
Figure 4-1: Mechanism of Nanomedicine to Destruct Tumor Cells
Figure 4-2: Vasculature of Tumor and Normal Cell
Figure 4-3: Nanoparticle Drug Delivery Benchmark
Figure 4-4: Liposomes as Nanocarriers
Figure 4-5: Structure of Dendrimers
Figure 4-6: Diverse Drug Release Mechanisms
Figure 5-1: Structure of Nanospheres and Nanocapsules
Figure 5-2: Processes Involved in Organic Polymeric Nanoparticles
Figure 5-3: Nanoparticle Production Methods
Figure 5-4: Different Categories of Emulsions
Figure 5-5: Scheme of Different Strategies of Interfacial Polymerization
Figure 5-6: Different Type of Inorganic Nanoparticle
Figure 5-7: Synthesis of Gold Nanoparticles
Figure 6-1: Functioning of Biosensors in Cancer Detection
Figure 6-2: Detection of Cancer Cells with Quantum Dots
Figure 7-1: Cancer Therapeutics with Nanomedicines
Figure 7-2: Cancer Cell Destruction via Nanomedicines
Figure 7-3: Drug Delivery across Blood Brain Barrier
Figure 8-1: Cancer Imaging Via Various Techniques
Figure 9-1: Nanomedicine and Cell Intake Mechanisms
Figure 9-2: Factors Affecting Drug Delivery
Figure 10-1: Global Nanomedicine Market (US$ Billion), 2013-2022
Figure 10-2: Global - Cancer Nanoparticle Pipeline by Phase (%), 2016 till 2022
Figure 10-3: Global - Cancer Nanoparticle Pipeline by Phase (Numbers), 2016 till 2022
Figure 10-4: Global - Cancer Nanoparticle Pipeline by Phase (%),2016 till 2022
Figure 10-5: Global - Cancer Nanoparticle Pipeline by Phase (Numbers), 2016 till 2022
Figure 11-1: Driving Parameters of Nanomedicines
Figure 11-2: Challenges of Nanomedicine Market
Figure 15-1: Arrowhead Research Corporation Clinical Pipeline
Figure 15-2: NanoCarrier Clinical Pipeline

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001
+91-11-47067990

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cancer Nanomedicine Market Outlook 2022 Report here

News-ID: 1040695 • Views: 381

More Releases from Kuick Resarch

Bi-specific Antibodies For Enhanced Killing of the Foreign Cells Invaders
The availability of bi-specific antibodies has triggered a fundamental shift in the treatment paradigm for broad spectrum disease. The big pool of data available for the complex human system and its coupling with the advanced analytics tools have helped the researchers to come up with a treatment procedure that is unique and hold maximum promising outcomes for the huge percentage of patient population in the world. Bi-specific antibodies represent
Artificial Immune Modulation Therapy, An Upcoming Breakthrough in the Global Imm …
The platform provided by artificial immune modulation therapy comprises of a specific artificial matrix for the modulation of different antigen-presenting cells, which is an important part in the immune system. The methodology involved in the artificial immune modulation therapy represents simple yet powerful action against challenging mechanism of the cancer development and progression. The therapy involves engineering and administration of the artificial presenting cells to the patients so that
Exploitation of Immune Cells for Gaining Maximum Positive Outcomes in Cancer Mar …
The approach that has been focused by the cancer immunotherapies have helped in transforming the global cancer therapeutics market. Its arrival in the market has assisted the researchers to overcome all the challenges and short-imperative approach that has been delivered by the other commercially available cancer therapies. The fundamental principle of the immunotherapy which involves the cells of the immune cells holds great potential and huge difference in delivering promising
Global Cell Therapy Market To Surpass US$ 400 Billion In Opportunity By 2027 Wit …
"Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027" Report Highlights: • Global Cell Therapy Market Opportunity: More Than USD 40 Billion By 2027 • Cell Therapy Clinical Trial Insight by Indication, Company and Country • Global Cell Therapy Clinical Pipeline: 1000 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Cell Therapy Trials For COVID-19: 10 Cell Therapies • Global COVID-19 Cell Therapy Clinical Trials By Phase & Company • COVID-19 Impact Analysis on Global market &

All 5 Releases


More Releases for Nanomedicine

Global Nanomedicine Market $185 Billion by 2021
The global nanomedicine market is estimated to reach $185 Billion in 2021, growing at a CAGR of 8.9% from 2017 to 2021, according to a market research report Nanomedicine Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc. Visit the Nanomedicine Market Analysis and Forecast 2017-2021 report at https://www.ihealthcareanalyst.com/report/nanomedicine-market/ Nanomedicine is the medical application of nanotechnology that ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and
Cancer Nanomedicine Market Cancer Nanomedicine Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Cancer Nanomedicine: An Optimistic Avenue 1.1 Introduction 1.2 Emergence of Nanomedicines Prerequisite of Nanomedicines 2.1 Conventional Cancer Treating Approaches 2.2 Nanomedicines: Overcoming the Hurdles Diversification of Nanomedicines 3.1 Classification on Basis of Constituents 3.1.1 Inorganic Nanoparticles 3.1.2 Organic Nanoparticles 3.2 Classification on Basis of Applicability 3.2.1
Global Cancer Nanomedicine Market & Cancer Nanomedicine Clinical Trials Outlook …
Over the past several years, many innovative and revolutionary techniques have been developed in order to treat cancer. These techniques range from basic surgical removal to X-ray irradiation to system wide flooding with anticancer agents. However, each of these approaches has its own series of undesirable side effects that are both dangerous and damaging to the overall health of the patient. On the contrary, very recent breakthroughs in nanomedicine have
Global Nanomedicine Market & Pipeline Insight 2015
Nanomedicines or nanotherapeutics is an emerging field in which nanotechnology principles are used to design and develop better therapeutics having high safety and efficacy profiles. It is a multidisciplinary approach utilizing knowledge from allied fields like biotechnology and pharmacology in drug development program. Novel modalities for cancer treatment, targeted drug delivery, biosensors, imaging, delivery vehicles and diagnostic methods are being actively investigated by pharmaceutical companies. They have been widely accepted
Global Cancer Nanomedicine Market Outlook 2022
Over the past several years, many innovative and revolutionary techniques have been developed in order to treat cancer. These techniques range from basic surgical removal to X-ray irradiation to system wide flooding with anticancer agents. However, each of these approaches has its own series of undesirable side effects that are both dangerous and damaging to the overall health of the patient. On the contrary, recent breakthroughs in nanomedicine have managed
Global Cancer Nanomedicine Market Outlook 2022
Over the past several years, many innovative and revolutionary techniques have been developed in order to treat cancer. These techniques range from basic surgical removal to X-ray irradiation to system wide flooding with anticancer agents. However, each of these approaches has its own series of undesirable side effects that are both dangerous and damaging to the overall health of the patient. On the contrary, recent breakthroughs in nanomedicine have managed